Share repurchase program to cover share plans completed

KAISERAUGST, Switzerland and MAASTRICHT, Netherlands, May 7, 2024 /PRNewswire/ -- dsm-firmenich today announces that, as part of its share repurchase program to cover share plans as announced on April 8, 2024, during the period from April 29, 2024 up to and including May 3, 2024 a total number of 547,165 shares have been repurchased on its behalf.

This completes the repurchase of in total 1,000,000 shares as part of an equity forward arrangement. The shares were repurchased at an average price of ?104.94 for a total amount of ?104.9 million.

For more detailed information see 'Daily transaction details Share Repurchase Program announced April 8, 2024 ? Equity Forward'.

Under the forward transaction dsm-firmenich expects to take delivery of the shares in 2025.

For more information, please contact:

dsm-firmenich investor relations enquiries:
Email: [email protected]

dsm-firmenich media enquiries:
Email: [email protected]   

About dsm-firmenich
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than ?12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to lifetm every day, everywhere, for billions of people. www.dsm-firmenich.com 

Disclaimer

This press release does not constitute or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This press release may contain forward-looking statements with respect to dsm-firmenich's future. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of this press release prevails over other language versions.

Logo - https://mma.prnewswire.com/media/2071772/dsm_firmenich_Logo.jpg